TOKYO, JAPAN – November 30, 2023 – Terumo Corporation today announced the establishment of a new subsidiary in South Africa, further expanding the company's global presence and strengthening its ability to serve customers across the African continent.
The new subsidiary will support sales and distribution of Terumo's medical device portfolio in South Africa and the broader region, enabling closer engagement with local healthcare providers and patients.
"Establishing a subsidiary in South Africa is an important step in our strategy to expand access to our products in emerging markets," said a Terumo representative. "We look forward to building strong relationships with healthcare partners across the region to help improve patient care."
This expansion reflects Terumo's ongoing commitment to its global growth strategy, extending the reach of its medical technologies to more patients around the world.
About Terumo
Terumo (TSE: 4543) is a leading global provider of medical products and solutions with net sales of 4 billion USD. Founded in 1921, Terumo employs over 30,000 associates worldwide, and its products and services are available in more than 160 countries and regions. Terumo's stated mission is "Contributing to Society through Healthcare."
